[Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology* / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D009203:Myocardial Infarction / Q000188:drug therapy*; D012770:Shock, Cardiogenic / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D004298:Dopamine
Die kardiovaskulären Wirkungen von Hydroxytyramin (Dopamin) und ihre Bedeutung für die Therapie des kardiogenen Schocks beim Herzinfarkt. 2. Experimentelle Untersuchungen am hypodynamen Hundeherzen.